Impact of Large Cells and Ki-67% on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - Results from a Multicenter Cohort Study

被引：0

作者：

Epperla, Narendranath ^{[1
,2
]}

Grover, Natalie S. ^{[3
]}

Annunzio, Kaitlin ^{[4
]}

Watkins, Marcus P. ^{[5
]}

Torka, Pallawi ^{[6
]}

Karmali, Reem ^{[7
,8
]}

Anampa-Guzman, Andrea Carolina ^{[9
]}

Oh, Timothy S. ^{[10
]}

Reves, Heather ^{[11
]}

Tavakkoli, Montreh ^{[12
]}

Hansinger, Emily ^{[13
]}

Christian, Beth ^{[4
]}

Thomas, Colin ^{[13
]}

Barta, Stefan K. ^{[14
]}

Geethakumari, Praveen Ramakrishnan ^{[15
]}

Bartlett, Nancy L. ^{[5
]}

Shouse, Geoffrey P. ^{[16
]}

Olszewski, Adam J. ^{[17
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH USA

[2] Richard J Solove Res Inst, Columbus, OH USA

[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Ohio State Univ, James Canc Ctr, Wexner Med Ctr, Columbus, OH USA

[5] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[7] Northwestern Univ, Div Hematol Oncol, Dept Med, Feinberg Sch Med, Chicago, IL USA

[8] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[9] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[11] Univ Texas Southwestern Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA

[12] Hosp Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA USA

[13] Thomas Jefferson Univ Hosp, Philadelphia, PA USA

[14] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[15] Univ Texas Southwestern Med Ctr Dallas, Sect Hematol Malignancies & Cellular Therapy, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA

[16] City Hope Comprehens Canc Ctr, Duarte, CA USA

[17] Brown Univ, Providence, RI USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-185152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL RealWorld Study Cohort
Epperla, Narendranath
Switchenko, Jeffrey M.
Geyer, Susan M.
Bachanova, Veronika
Barta, Stefan K.
Danilov, Alexey
Grover, Natalie S.
Karmali, Reem
Hill, Brian T.
Ghosh, Nilanjan
Fenske, Timothy S.
Martin, Peter
Kahl, Brad S.
Flowers, Christopher R.
Link, Brian K.
Hsi, Eric D.
Maddocks, Kami J.
Blum, Kristie A.
Habermann, Thomas M.
Maurer, Matthew J.
Kaplan, Lawrence David
Bartlett, Nancy L.
Leonard, John P.
Cohen, Jonathon B.
BLOOD, 2023, 142
[42] Long-term outcomes of solitary functioning kidney in children: results from a large multicenter cohort study
In 't Woud, Sander Groen
Roeleveld, Nel
Feitz, Wout
van der Zanden, Loes
Schreuder, Michiel
PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2258 - 2258
[43] Impact of Extramedullary Disease on Outcomes in Newly Diagnosed Multiple Myeloma Patients: A Retrospective Study from a Single Center
Ghahramanyan, Nerses
Avagyan, Manushak
Ghazaryan, Narine
Oganesyan, Artem
Ghazaryan, Marina
Danielyan, Samvel
Tamamyan, Gevorg
Hakobyan, Yervand
Bardakhchyan, Samvel
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S489 - S490
[44] The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study
Tshimologo, Maatla
Helliwell, Toby
Hider, Samantha
Mallen, Christian
Muller, Sara
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2018, 20
[45] Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib
Goy, Andre
Williams, Michael E.
Besisik, Sevgi Kalayoglu
Drach, Johannes
Ramchandren, Radhakrishnan
Robertson, Michael J.
Avivi, Irit
Rowe, Jacob M.
Herbrecht, Raoul
Van Hoof, Achiel
Egyed, Miklos
Zhang, Lei
Cicero, Sherri
Fu, Tommy
Heise, Carla
Witzig, Thomas E.
BLOOD, 2013, 122 (21)
[46] Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea
Moon, Jung Rock
Lee, Chang Kyun
Hong, Sung Noh
Im, Jong Pil
Ye, Byong Duk
Cha, Jae Myung
Jung, Sung-Ae
Lee, Kang-Moon
Park, Dong Il
Jeen, Yoon Tae
Park, Young Sook
Cheon, Jae Hee
Kim, Hyesung
Seo, BoJeong
Kim, Youngdoe
Kim, Hyo Jong
GUT AND LIVER, 2020, 14 (04) : 459 - 467
[47] Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study
Holten, Kristina I. Aass
Bernklev, Tomm
Opheim, Randi
Johansen, Ingunn
Olsen, Bjorn C.
Lund, Charlotte
Strande, Vibeke
Medhus, Asle W.
Perminow, Gori
Bengtson, May-Bente
Cetinkaya, Raziye Boyar
Vatn, Simen
Frigstad, Svein Oskar
Aabrekk, Tone B.
Detlie, Trond Espen
Hovde, Oistein
Kristensen, Vendel A.
Smastuen, Milada Cvancarova
Henriksen, Magne
Huppertz-Hauss, Gert
Hoivik, Marte Lie
Jelsness-Jorgensen, Lars-Petter
JOURNAL OF CROHNS & COLITIS, 2023, 17 (11): : 1781 - 1790
[48] Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort
Stahl, Maximilian
Wei, Wei
Montesinos, Pau
Lengline, Etienne
Shallis, Rory M.
Neukirchen, Judith
Bhatt, Vijaya R.
Sekeres, Mikkael A.
Fathi, Amir T.
Konig, Heiko
Luger, Selina
Khan, Irum
Roboz, Gail J.
Cluzeau, Thomas
Martinez-Cuadron, David
Raffoux, Emmanuel
Germing, Ulrich
Umakanthan, Jayadev Manikkam
Mukherjee, Sudipto
Brunner, Andrew M.
Miller, Adam M.
McMahon, Christine M.
Ritchie, Ellen K.
Rodriguez-Veiga, Rebeca
Itzykson, Raphael
Boluda, Blanca
Rabian, Florence
Tormo, Mar
Acuna Cruz, Evelyn Gloria
Rabinovich, Emma
Yoo, Brendan
Podoltsev, Nikolai A.
Gore, Steven D.
Zeidan, Amer M.
BLOOD, 2018, 132
[49] Ofatumumab Is Active and Safe in Patients with Relapsed/Refractory Splenic Marginal Zone Lymphoma (SMZL): Results from the Interim Analysis of an Italian Multicenter Phase 2 Study (MORE trial)
Scarfo, Lydia
Ferrari, Silvia
Frustaci, Annamaria Maria
Tani, Monica
Pozzi, Samantha
Scarano, Eloise
Colia, Maria
Ranghetti, Pamela
Ponzoni, Maurilio
Ronchi, Paola
Ferreri, Andres J. M.
Ghia, Paolo
BLOOD, 2018, 132
[50] Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study
Houvenaeghel, G.
Cohen, M.
Classe, J. M.
Reyal, F.
Mazouni, C.
Chopin, N.
Martinez, A.
Darai, E.
Coutant, C.
Colombo, P. E.
Gimbergues, P.
Chauvet, M. P.
Azuar, A. S.
Rouzier, R.
de Lara, C. Tunon
Muracciole, X.
Agostini, A.
Bannier, M.
Jauffret, E. Charaffe
De Nonneville, A.
Goncalves, A.
ESMO OPEN, 2021, 6 (06)

← 1 2 3 4 5 →